ID
21870
Description
Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00411528
Link
https://clinicaltrials.gov/show/NCT00411528
Keywords
Versions (1)
- 5/5/17 5/5/17 -
Uploaded on
May 5, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Hormone Refractory Prostate Cancer DRKS00007583 NCT00411528
Eligibility Metastatic Hormone Refractory Prostate Cancer NCT00411528
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Therapeutic radiology procedure
Data type
boolean
Alias
- UMLS CUI [1]
- C1522449
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
Peripheral Neuropathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0031117
Description
Diarrhea
Data type
boolean
Alias
- UMLS CUI [1]
- C0011991
Description
Illness | Heart Disease | Diabetes Mellitus | Communicable Diseases chronic | Communicable Diseases Uncontrolled
Data type
boolean
Alias
- UMLS CUI [1]
- C0221423
- UMLS CUI [2]
- C0018799
- UMLS CUI [3]
- C0011849
- UMLS CUI [4,1]
- C0009450
- UMLS CUI [4,2]
- C0205191
- UMLS CUI [5,1]
- C0009450
- UMLS CUI [5,2]
- C0205318
Description
Allergic Reaction epothilone B | Allergic Reaction docetaxel | Prednisone allergy | Allergic Reaction Compound Similar
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1527304
- UMLS CUI [1,2]
- C0297960
- UMLS CUI [2,1]
- C1527304
- UMLS CUI [2,2]
- C0246415
- UMLS CUI [3]
- C0571591
- UMLS CUI [4,1]
- C1527304
- UMLS CUI [4,2]
- C1706082
- UMLS CUI [4,3]
- C2348205
Description
Clinical Trial Eligibility Criteria Study Protocol
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348563
Similar models
Eligibility Metastatic Hormone Refractory Prostate Cancer NCT00411528
- StudyEvent: Eligibility
C0332120 (UMLS CUI [1,2])
C1328504 (UMLS CUI [2])
C0919936 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0297960 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C0571591 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
C2348563 (UMLS CUI [1,2])